Showing results (221-230 of 447) with videos related to
Sort By:
Pageof 45
Pain|January 26, 2018
Lateralized kappa opioid receptor signaling from the amygdala central nucleus promotes stress-induced functional painKelsey M Nation, Milena De Felice, Pablo I Hernandez, et al.Pain and Therapy|October 7, 2020
The Impact of OnabotulinumtoxinA vs. Placebo on Efficacy Outcomes in Headache Day Responder and Nonresponder Patients with Chronic MigraineStephen D Silberstein, Hans-Christoph Diener, David W Dodick, et al.Headache|September 2, 2017
Fremanezumab as Add-On Treatment for Patients Treated With Other Migraine Preventive MedicinesJoshua M Cohen, David W Dodick, Ronghua Yang, et al.Journal of Neurology, Neurosurgery, and Psychiatry|February 19, 2016
Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and managementSusan P Mollan, Fizzah Ali, Ghaniah Hassan-Smith, et al.Headache|April 8, 2017
Insights into the Functional Anatomy Behind the PREEMPT Injection Paradigm: Guidance on Achieving Optimal OutcomesAndrew M Blumenfeld, Stephen D Silberstein, David W Dodick, et al.Cephalalgia : an International Journal of Headache|March 7, 2020
Acute treatment patterns in patients with migraine newly initiating a triptanRichard B Lipton, Steven C Marcus, Anand R Shewale, et al.Pain and Therapy|October 7, 2020
Benefits Beyond Headache Days With OnabotulinumtoxinA Treatment: A Pooled PREEMPT AnalysisHans-Christoph Diener, David W Dodick, Richard B Lipton, et al.Headache|June 26, 2020
Open-Label, Multi-Dose, Pilot Safety Study of Injection of OnabotulinumtoxinA Toward the Otic Ganglion for the Treatment of Intractable Chronic Cluster HeadacheJoan Crespi, Daniel Bratbak, David W Dodick, et al.Headache|October 16, 2025
Telemedicine is effective and safe for clinical management of patients with headache disorders: An American Headache Society position statementKarissa N Arca, Allyson B Bazarsky, Derek Y Yuan, et al.Cephalalgia : an International Journal of Headache|June 26, 2019
Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trialDavid W Dodick, Richard B Lipton, Stephen Silberstein, et al.Pageof 45